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ABSTRACT
Alternative splicing is emerging as a major mech-
anism for the expansion of the transcriptome and
proteome diversity, particularly in human and other
vertebrates. However, the proportion of alterna-
tive transcripts and proteins actually endowed
with functional activity is currently highly debated.
We present here a new release of ASPicDB which
now provides a unique annotation resource of
human protein variants generated by alternative
splicing. A total of 256 939 protein variants from
17 191 multi-exon genes have been extensively
annotated through state of the art machine learn-
ing tools providing information of the protein type
(globular and transmembrane), localization,
presence of PFAM domains, signal peptides, GPI-
anchor propeptides, transmembrane and coiled-
coil segments. Furthermore, full-length variants can
be now specifically selected based on the annotation
of CAGE-tags and polyA signal and/or polyA sites,
marking transcription initiation and termination
sites, respectively. The retrieval can be carried out
at gene, transcript, exon, protein or splice site level
allowing the selection of data sets fulfilling one or
more features settled by the user. The retrieval inter-
face also enables the selection of protein vari-
ants showing specific differences in the annotated
features. ASPicDB is available at http://www
.caspur.it/ASPicDB/.
INTRODUCTION
Alternative splicing is a well characterized mechanism
which, coupled with alternative initiation and termination
of transcription (1), may expand the transcriptome and
proteome complexity in human and other organisms by
over one order of magnitude with respect to the number of
annotated genes (2,3). In particular, it is now widely
demonstrated that virtually all multi-exon genes may
generate multiple transcripts and protein variants (3,4)
and that the splicing process is tightly regulated in differ-
ent physiological conditions, tissues or developmental
stages (5). Furthermore, alterations of the splicing
process can be observed in several genetic diseases and
in cancer (6–10).
The huge amount of EST sequences (11) together with
the relevant reference genome sequence has been used to
carry out an extensive analysis of alternative splicing in
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human through the ASPIC algorithm (12–14). The alter-
native splicing pattern of human multi-exon genes,
determined by ASPIC, has been collected in ASPicDB, a
database resource which presents some unique features
with respect to other similar databases (15). The ASPIC
algorithm implements an optimization strategy that, per-
forming a multiple alignment of all available transcript
data (including full-length cDNA and EST sequences) to
the relevant genome sequence, detects the set of introns
that minimizes the number of splicing sites. It also gener-
ates through a directed-acyclic graph combinatorial
procedure the minimal set of non-mergeable transcript
isoforms compatible with the detected splicing events
(14). The reliability of splicing isoforms detected
by ASPIC has been recently established through a
comparative assessment (16).
The advent of massive transcriptome sequence data
generated by RNA-Seq (17) is steadily increasing the
number of validated splicing sites and isoforms in
human and other organisms thus suggesting that a
fraction of alternative splicing events are the result of
background noise in the splicing process (18) which gen-
erates non-functional isoforms expressed at low level.
Therefore, extensive research efforts are required to dis-
tinguish functional species-specific variants from
non-functional ones originated from neutral drift in the
splicing process, as well as to asses the biological role of
functional isoforms.
The annotation of the protein variants predicted with
ASPIC is an essential step for exploring the functional
and structural diversity of the proteins originating
from the same gene by means of alternative splicing and
therefore for unraveling the complex physiological effects
of alternative splicing events (19). Indeed, currently avail-
able databases, such as ASD (20), ASAP II (21),
ASTALAVISTA (22) and H-DBAS (23), mostly collect
information on alternative transcripts at the mRNA level,
without considering the effect of alternative splicing on the
protein structure and function. The ProSAS (24) database
contains structural information as derived from compara-
tive modeling procedure, but due to the limitations of the
modeling techniques, only 15% of the human transcripts
are endowed with a reliable protein structure prediction.
ASPICdb aims at filling the gap of structural and func-
tional annotation of protein splicing variants, by adopting
a set of analysis and prediction tools that do not rely only
on annotation transfer by sequence similarity. It provides
a thorough computational annotation of predicted human
protein variants including PFAM domains (25),
N-terminal signal peptides, GPI-anchor propeptides,
transmembrane domains, subcellular localization and
other features, also reporting the relevant crosslinks to
UniprotKB/Swissprot (26) and PDB databases (27). A
comprehensive annotation of the domain architecture
and other structural features could also be extremely
useful to critically assess the reliability of the functional
classification provided the GO System (25), which still
neglects much of the relevant information for alternative
splicing products.
In addition, in consideration of the fragmented nature
of the available transcript data, the new version of
ASPicDB include the annotation of CAGE tags (28) in
order to identify truly transcription initiation sites and
discriminate between full-length isoforms using alternative
transcription initiations and 50-partial transcripts for
which a full-length CDS and the encoded protein cannot
be reliably predicted.
ANNOTATION PIPELINE OF HUMAN PROTEIN
VARIANTS
The computational pipeline implemented for supplement-
ing the ASPicDB protein sequences with functional and
structural annotations is represented in Figure 1 and inte-
grates several state-of-the-art tools for similarity search
and for machine-learning based prediction of protein
features starting from residue sequence.
For each one of the 256 939 protein variants coming
from 17 191 human genes, a first layer of annotation
consists in the retrieval of similar sequences from the two
major repositories containing well-characterized proteins,
namely: (i) the UniProtKB/SwissProt data base (26)
(rel. 2010_07, June 2010), that contains 547 011 protein
sequences with curated annotations, including 517 802
principal entries and 29 209 splicing variants (UniProt
Consotium, 2010); (ii) the Protein Data Bank (rel. July
2010), that contains resolved three dimensional structures
for 50 171 different protein sequences (29).
Similarity searches were performed with BLAST (30)
setting the E-value threshold to 103.
A second layer of annotation is obtained by mapping the
structural and functional domains collected in the
Figure 1. Pipeline for the annotation of alternative transcripts.
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PFAM-A database (rel. 24.0, October 2009) that contains
curated multiple sequence alignments based on hidden
Markov models (HMM) for 8691 families, 2985 domains,
162 repeats and 74 motifs (25). The PFAM models were
mapped on the ASPicDB protein sequences by means of
the pfam_scan.pl program (ftp://ftp.sanger.ac.uk/pub/
databases/Pfam/Tools/), based on HMMER3.0 (31).
The third layer of annotation results from the integra-
tion of several predictors based on machine learning tools,
such as neural networks, hidden Markov models, support
vector machines and conditional random fields. Since
most of the methods take advantage of the evolutionary
information encoded in sequence profiles, we compiled
them starting from the similar sequences retrieved with
two PSI-BLAST iterations (setting the E-value threshold
to 103) from the UniRef90 data set consisting of
6 955 504 sequences (July 2010). The first predicted
features are the presence of N-terminal signal peptide
and of C-terminal GPI-anchor propeptides, with
SPEPlip (32) and PredGPI (33), respectively. Both the
methods are among the best available predictors, scoring
with accuracy as high as 95% the former and 88% the
latter. When present, the signal peptide and the propeptide
are cleaved from the protein sequence. The presence of
coiled-coil domains is predicted with CCHMM-PROF
that is able to locate coiled-coil segments in protein se-
quences with 80% accuracy (34). a-Helical transmem-
brane domains are then predicted with ENSEMBLE
(35), that discriminates transmembrane from globular
proteins with false positive and false negative rates both
equal to 3%. The same tool is adopted for predicting the
number and the position of transmembrane segments
along the sequence, with an accuracy of 90% on the
protein base. The subcellular localization of globular
proteins is predicted with BaCelLo (36), which discrimin-
ates four localizations in animals (secretory pathway,
cytoplasm, nucleus and mitochondrion) with 74%
accuracy.
ASPicDB CONTENT AND ANNOTATION OF
PROTEIN VARIANTS
Table 1 reports some statistics on the data contained in the
current version of ASPicDB (version 2.0, August 2010)
which refers only to human multi-exon genes annotated
in NCBI Entrez Gene (37) with at least one RefSeq
transcript (38) and the relevant Unigene cluster (39)
collecting all available gene-specific cDNA and EST
sequences.
In the current version of ASPicDB some more features
are available including the annotation of the CAGE tags
(28) which define truly transcription initiation sites and a
comprehensive protein annotation. A total of 12 789 394
CAGE tags have been mapped thus supporting constitu-
tive or alternative transcription start sites. To each tran-
script variant a ‘unique identifier’ (16) has been associated
in order to make possible the unambiguous comparison
with alternative transcripts collected in other databases.
All alternative proteins collected in ASPicDB have been
compared with UniprotKB/SwissProt (26) and PDB (29)
databases. The results of similarity searches are reported
in Table 2. Only 17% of the ASPicDB protein sequences
are identical to proteins deposited in UniProtKB/
SwissProt database. However, 94% of the sequences
share significant similarity with proteins annotated in the
same database, prompting the possibility of a reliable an-
notation transfer. Moreover, 54% of ASPicDB sequences
are similar to proteins deposited in the PDB suggesting
that their structures can be modeled, at least partially.
A considerable amount of PFAM models map on the
ASPicDB sequences (Table 2). On the overall, 71% of
sequences match with at least one model. This result is
in agreement with the reported sequence coverage on the
human proteome of the current PFAM release, which is
equal to 72.5% (25). It is worth noticing that, although all
the models map with an E-value < 105, only 20% of the
matches are complete (that is, involve the whole model). A
note of caution is necessary when inferring features from
partial matches and the actual extent of the match has to
be evaluated for each instance.
Table 3 summarizes the results of the annotation
process performed with machine learning based predict-
ors. Two percent of proteins were not predicted since they
are shorter than 50 residues, 16% of proteins are predicted
as transmembrane and 82% are predicted as globular.
Among the globular proteins, 12% are predicted as
secreted, 35% as cytoplasmic, 27% as globular and 8%
as mitochondrial. Signal peptides and GPI-anchor
propeptides are predicted in the 12 and 0.7% of the
Table 2. Annotation of human variants upon similarity and PFAM
searches
Sequence repository No of proteinsa No of genesa
UniProtKB/SwissProt, %
E-value< 103, % 239 814 (93) 17 054 (99)
Identical, % 42 601 (17) 13 043 (76)
PDB
E-value< 103, % 137 528 (54) 11 062 (64)
Identical, % 1079 (0.4) 316 (2)
PFAM
All matches, E-value< 105, % 183 483 (71) 14 205 (83)
Complete matches,
E-value< 105, %
46 630 (18) 5621 (33)
aThe percentages are computed with respect to 256 939 protein variants
and 17 191 genes.
Table 1. Statistics of the ASPicDB content (v2.0, August 2010)
ASPicDB v2.0
Genes 17 191
Transcripts 319 092
Proteins 256 939
Exons 390 886
Splicing sites 351 345
U2 302 164
U12 1712
Splicing events 233 717
The number of splicing sites belonging to the U2 or U12 class and of
splicing events is also reported.
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sequences, respectively. Coiled-coil domains are predicted
in 1.3% of the proteins. At the gene level, 30 and 92% of
genes encode for transmembrane and globular proteins,
respectively. Since the sum exceed 100%, it follows that
22% of the genes encode for both globular and transmem-
brane variants. The same consideration holds for the other
annotations as reported in Table 4. The amount of genes
predicted to encode for proteins with different subcellular
localization achieves 56%. This is partially explained by
the fact that BaCelLo scores with an accuracy equal to
74%, which is the lowest among the methods included in
the pipeline. Indeed the discrimination between the ‘cyto-
plasmic’ and the ‘nuclear’ classes is still a difficult task for
all subcellular localization predictors (40). When the two
classes are merged together, the BaCelLo accuracy in-
creases up to 91%, but the rate of genes encoding for
proteins with different localizations is still as high as
44%, suggesting that localization diversity is inherent in
the ASPicDB protein variants. The structure of PFAM
annotations is also highly variable: 38% of genes encode
for variants matching with different number and/or type
of PFAM models. Altogether, results listed in Table 4
suggest that alternative transcripts can encode for
proteins endowed with different structural and functional
features. ASPicDB provides a unique resource reporting
the annotation of alternative splicing variants at the
protein level and an interface enabling the discovery of
such differences.
ASPicDB RETRIEVAL INTERFACE
ASPicDB can be accessed though simple or advanced
query forms. The simple query form allows the user to
obtain the splicing pattern of one or more genes selected
according to several criteria (e.g. HGNC name, RefSeq or
Unigene accession IDs, etc.). The advanced query form
allows the user to search for (i) genes, (ii) transcripts;
(iii) exons; (iv) splicing sites; and (v) proteins, fulfilling
different criteria (e.g. exons in a given length range,
etc.). Depending on the choice separate query forms
appear. The ‘gene’, ‘transcript’ and ‘splicing sites’ query
forms have been described previously (15) whereas the
‘exon’ and ‘protein’ query forms are novel features of
this version of ASPicDB. The exon query form allows
the user to select exons in a given length range, belonging
to a specific type (initial, internal or teminal), flanked by
specific splicing sites or associated to one or more
Affimetrix ExonArray probeset IDs.
The ‘protein’ query form allows the retrieval of tran-
scripts encoding proteins isoforms of a specific class (e.g.
globular or transmembrane), subcellular localization (e.g.
mitochondrion, nucleus, secretory, cytoplasm) or contain-
ing one or more features, including occurrence and
number of PFAM or transmembrane domains, GPI-
anchor propeptides, signal peptides. Finally, it is also
possible to retrieve genes encoding for alternative
proteins that show differences in the above mentioned
features.
ASPicDB OUTPUT
After a simple or advanced query has been submitted the
output for each selected gene is shown which is organized
in eight panels.
(1) Gene information reports a summary of the genomic
and transcript data used by ASPIC to generate the
prediction, downloadable by the user and links to
other popular prediction programs such as ASAP2
(21), ASD (20) and ACEVIEW (41) as well as to
ASPIC results for orthologous genes in other species.
(2) Gene structure view provides a schematic graphical
view of the gene structure including all predicted
exons/introns.
(3) Predicted transcripts show a graphical representation
of the assembled transcripts with predicted annota-
tions of 50-UTR, CDS and 30-UTR, CAGE tag
mapping, Premature Termination Codons (PTC)
and polyA sites.
(4) Transcript table lists the details of all predicted alter-
native transcripts including their length, number of
exons and presence of a protein coding sequence.
The ‘variant type’ column lists all the alternative
splicing events using a RefSeq mRNA as the refer-
ence transcript. The transcript signature is also
reported which consists in a unique ID for alterna-
tively spliced variants generated according to (16).
(5) Predicted proteins show a graphical representation
of the encoded proteins with matching domains
(Figure 2). For each mapped domain the sequence
Table 3. Machine learning-based prediction of the human proteins
deposited ASPicDB
Annotation No. of proteinsa No. of genesa
Type
Globular, % 210 608 (82) 15 513 (90)
Transmembrane, % 41 561 (16) 5439 (32)
Localization (globular proteins)
Secretory pathway, % 31 917 (12) 7348 (43)
Cytoplasm, % 90 046 (35) 10 327 (60)
Nucleus, % 69 167 (27) 8183 (48)
Mitochondrion, % 19 478 (8) 4698 (27)
Domains
Signal peptide, % 30 508 (12) 5153 (30)
GPI-anchor propeptide, % 1673 (0.7) 629 (4)
Coiled-coil segments, % 3423 (1.3) 497 (2.8)
aThe percentages are computed with respect to 256 939 protein variants
and 17 191 genes.
Table 4. Differences among alternative proteins encoded by the same
human gene
Annotation No. of genesa, %
Type (globular/transmembrane) 3817 (22)
Subcellular localization (globular proteins) 9593 (56)
Presence of signal peptide 3939 (23)
Presence of GPI-anchor propeptide 591 (3.4)
Presence of coiled-coil domains 464 (2.7)
Number of transmembrane helices 2140 (12)
PFAM models (all matches) 6575 (38)
aThe percentages are computed with respect to 17 191 genes.
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coordinates are reported and different symbols
indicate whether the mapping involves the complete
domain or only a part of it.
(6) Protein table lists the predicted features of the alter-
native proteins that include: (i) the best hits obtained
from the similarity searches against the UniProtKB/
SwissProt and PDB databases, along with the
identity value and coverage of the alignment with
respect to both the query and the subject sequence
lengths; (ii) the features predicted by the pipeline
based on machine-learning tools.
(7) Predicted splice sites shows the multiple alignment
between the genomic sequence and the expressed se-
quences (i.e. mRNAs and ESTs) near the boundaries
(splice sites) of all predicted introns.
(8) Intron table lists all predicted introns and their
relevant features; All results can be also downloaded
by the user in textual format following the ‘gene
transfer format’ (GTF) (see the Gene Information
panel).
After a query at the gene, transcript, exon, protein or
splice site level has been completed, the user can also
download specific sets of sequences in FASTA format
for further analyses, e.g. genes, transcripts, exons,
proteins, 50-UTRs, coding sequences, 30-UTRs, introns
as well as sequence regions surrounding splice site
boundaries.
FUTURE PERSPECTIVES
ASPicDB is an ongoing project and we plan to further
develop it in the next releases. In particular we plan to
add specific annotations on splicing regulatory elements
and their interacting RNA-binding proteins located both
in exonic and intronic regions. We also plan to update
alternative splicing prediction by using the huge amount
of RNA-Seq data which are now being produced by next
generation sequencing, possibly annotating splicing events
as constitutive or tissue-specific. Furthermore, literature-
screened splicing patterns related to diseases will be
annotated as they represent potential molecular biomark-
ers and possible targets for therapy. Finally, the inclusion
in the database of data related to other organisms will
certainly favor a better understanding of the alternative
splicing process through comparative analyses.
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